Log in to save to my catalogue

Omalizumab for the Treatment of Multiple Food Allergies

Omalizumab for the Treatment of Multiple Food Allergies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2932020459

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Food allergies are common and are associated with substantial morbidity; the only approved treatment is oral immunotherapy for peanut allergy.
In this trial, we assessed whether omalizumab, a monoclonal anti-IgE antibody, would be effective and safe as monotherapy in patients with multiple food allergies. Persons 1 to 55 years of age who were al...

Alternative Titles

Full title

Omalizumab for the Treatment of Multiple Food Allergies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2932020459

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2932020459

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2312382

How to access this item